Literature DB >> 18329535

Diagnosis and management of scleroderma peripheral vascular disease.

Ariane Herrick1.   

Abstract

The manifestations of peripheral vascular disease in patients who have systemic sclerosis (SSc) range from episodic Raynaud's phenomenon to irreversible tissue injury with ulceration and gangrene. Structural and functional changes may occur in the microvessels, digital arteries, and sometimes more proximal vessels. This article discusses the assessment of patients who have Raynaud's phenomenon in whom an underlying scleroderma-spectrum disorder is suspected and patients who have SSc with critical digital ischemia/ulceration. Different imaging techniques, including capillaroscopy and angiography, complement the history and examination, and developments in vascular imaging should facilitate future studies of pathogenesis and treatment response. New vasoactive treatments are currently being researched and older treatments revisited; therefore new approaches to therapy will likely be developed over the next 5 to 10 years.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18329535     DOI: 10.1016/j.rdc.2007.11.006

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  13 in total

Review 1.  Daily dosing of PDE5 inhibitors: where does it fit in?

Authors:  King Chien Joe Lee; Gerald B Brock
Journal:  Curr Urol Rep       Date:  2013-08       Impact factor: 3.092

2.  Association between endothelial function and microvascular changes in patients with secondary Raynaud's phenomenon.

Authors:  Ji Hyun Le; Kyoung Im Cho
Journal:  Clin Rheumatol       Date:  2014-03-11       Impact factor: 2.980

3.  Phosphodiesterase inhibitors in vascular ischemia: A case report and review of their use in ischemic conditions.

Authors:  Wendy Ky Ng; Yishai Rosenblatt; Gerald B Brock; David B O'Gorman; Bing Siang Gan
Journal:  Can J Plast Surg       Date:  2010

Review 4.  Assessing microvascular changes in systemic sclerosis diagnosis and management.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Nat Rev Rheumatol       Date:  2010-08-10       Impact factor: 20.543

5.  Comparison of laser Doppler imaging, fingertip lacticemy test, and nailfold capillaroscopy for assessment of digital microcirculation in systemic sclerosis.

Authors:  Marcelo Ju Correa; Luis Ec Andrade; Cristiane Kayser
Journal:  Arthritis Res Ther       Date:  2010-08-10       Impact factor: 5.156

6.  Digital ischemic loss in systemic sclerosis.

Authors:  Umaima Marvi; Lorinda Chung
Journal:  Int J Rheumatol       Date:  2010-08-24

7.  Osteomyelitis complicating scleroderma digital ulcers.

Authors:  Dilia Giuggioli; Andreina Manfredi; Michele Colaci; Federica Lumetti; Clodoveo Ferri
Journal:  Clin Rheumatol       Date:  2013-01-11       Impact factor: 2.980

Review 8.  The role of capillaroscopy in differentiation of primary and secondary Raynaud's phenomenon in rheumatic diseases: a review of the literature and two case reports.

Authors:  Sevdalina Nikolova Lambova; Ulf Müller-Ladner
Journal:  Rheumatol Int       Date:  2009-06-23       Impact factor: 2.631

9.  Erectile dysfunction is frequent in systemic sclerosis and associated with severe disease: a study of the EULAR Scleroderma Trial and Research group.

Authors:  Chingching Foocharoen; Alan Tyndall; Eric Hachulla; Edoardo Rosato; Yannick Allanore; Dominique Farge-Bancel; Paola Caramaschi; Paolo Airó; Starovojtova M Nikolaevna; José António Pereira da Silva; Bojana Stamenkovic; Gabriela Riemekasten; Simona Rednic; Jean Sibilia; Piotr Wiland; Ingo Tarner; Vanessa Smith; Anna T Onken; Walid Ahmed Abdel Atty Mohamed; Oliver Distler; Jadranka Morović-Vergles; Andrea Himsel; Paloma Garcia de la Peña Lefebvre; Thomas Hügle; Ulrich A Walker
Journal:  Arthritis Res Ther       Date:  2012-02-20       Impact factor: 5.156

10.  Photoacoustic Oxygenation Quantification in Patients with Raynaud's: First-in-Human Results.

Authors:  John R Eisenbrey; Maria Stanczak; Flemming Forsberg; Fabian A Mendoza-Ballesteros; Andrej Lyshchik
Journal:  Ultrasound Med Biol       Date:  2018-07-06       Impact factor: 2.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.